OOIR: Observatory of International Research

Papers

(The TQCC of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
3136 – LOSS OF CD36 EXPRESSION HAS LIMITED IMPACT ON NORMAL HEMATOPOIESIS	58
3077 – FUNCTIONAL AND MOLECULAR IDENTIFICATION OF A FETAL-ASSOCIATED TUMOR SUPPRESSOR AXIS: ABROGATION OF MLL-ENL DRIVEN ACUTE MYELOID LEUKEMIA	36
3054 – CROSSTALK AT THE MATERNAL-FETAL INTERFACE CONSTRAINS FETAL HEMATOPOIETIC STEM AND PROGENITOR CELL RESPONSE TO INFLAMMATION.	33
3010 – REJUVENATING BLOOD STEM CELLS EXTENDS LIFESPAN OF AGED IMMUNOCOMPROMISED MICE	27
3163 – MODULATION OF RNA POLYMERASE II ACTIVITY REGULATES HUMAN HSC SELF-RENEWAL	20
Cover 2: Editorial Board	19
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib	18
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.	16
3219 – RNA DEADENYLATION SUBUNIT CNOT3 PROMOTES MYELOID LEUKEMIA BY DRIVING TRANSLATION OF ONCOGENIC TARGETS	16
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO	16
1006 – TRANSCRIPTIONAL ALTERATIONS AND ONTOGENY IN PEDIATRIC ACUTE MYELOID LEUKEMIA	15
1023 – UNRAVEL THE ROLE OF THE VASCULAR NICHE IN THE LEUKEMIC MICROENVIRONMENT	15
3103 – NITRIC OXIDE-DEPENDENT VASODILATION MAINTAINS THE PHYSIOLOGICAL OXYGEN LEVELS IN BONE MARROW AND ALLOWS LOCAL CRAWLING OF HEMATOPOIETIC STEM CELLS	14
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING	14
3055 – REGULATION OF PROTEIN SYNTHESIS IN LEUKEMIA STEM CELLS	14
1022 – GENE THERAPY FOR BETA-THALASSEMIA: FROM THE BENCH TO THE BEDSIDE AND BACK	14
1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS	14
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS	13
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]	12
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION	12
RNA methylation: where to from here for hematologic malignancies?	12
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE	12
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL	12
Corrigendum to <‘Novel therapeutic strategies for multiple myeloma’> <[Experimental Hematology 2015; 43: 732-741]>	12
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS	12

3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION	11
IFC Editorial Board	11
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA	11
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE	11
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs	11
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN	11
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage	11
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS	10
3040 – DRUG DISCOVERY FOR INHIBITORS OF PHAGOCYTOSIS FOR USE IN IMMUNE CYTOPENIAS	10
3065 – CRISPR MODELING OF ACUTE MYELOID LEUKEMIA MUTATIONS IN PRIMARY HEMATOPOIETIC STEM CELLS TO STUDY (PRE-)LEUKEMIA DEVELOPMENT	10
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e5	10
2019 – SYSTEMIC AND LOCAL REGULATION COOPERATES TO DETERMINE HEMATOPOIETIC STEM CELL NUMBERS	10
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA	10
Distinct transcriptional changes in hematopoietic progenitor subsets upon LPS-induced emergency granulopoiesis	10
3006 – JAK2 PHOSPHORYLATES THE RNA PROCESSING PROTEIN HNRNPA1 TO REPRESS THE EXPRESSION OF RETROTRANSPOSONS AND PROTECT THE HAEMATOPOIETIC STEM CELL GENOME	10
3114 – FROM MECHANISMS OF LEUKAEMOGENIC DYSREGULATION TO NEW CANDIDATE THERAPEUTICS	10
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS	9
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL1	9
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION	9
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT	9
Bone marrow transplantation without myeloablative conditioning in a mouse model for Diamond-Blackfan anemia corrects the disease phenotype	9
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION	9
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS	9
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES	9
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY	8
1001 – FROM METCALF TO MYELOPROLIFERATIVE MALIGNANCIES – A PERSONAL VOYAGE	8
3063 – RESTORING THE IMMUNOGENICITY OF CANCER CELLS WITH DENDRITIC CELL REPROGRAMMING	8
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA	8
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION	8
3072 – TYPE I AND II INTERFERONS CONVERGE TO INDUCE HEMATOPOIETIC SUPPRESSION VIA IL-18-INDUCED CELL DEATH DURING SEVERE INFECTION	8
Cover 2: Editorial Board	8
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW	8
3058 – SARS-COV-2 BINDING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS UNDER LOW OXYGEN CONDITIONS	8
3005 – GROUP F SOX GENES CONTROL HUMAN EMBRYONIC VASCULAR PATTERNING VIA NOTCH SIGNALING	8
3076 – M. AVIUM INDUCES TRAINED IMMUNITY THAT IS SPECIFIC AND HETEROGENEOUS WITHIN THE HEMATOPOIETIC STEM AND PROGENITOR CELL (HSPC) POPULATION	7
3123 – POLYBROMO SWI/SNF INTEGRATES CHROMATIN REMODELING & BMP/TGF-Β SIGNALING TO DETERMINE MESENCHYMAL STROMAL OSTEOLINEAGE COMMITMENT AND HEMATOPOIESIS	7
3079 – UNDERSTANDING OF HEMATOPOIETIC STEM CELL SYMMETRIC AND ASYMMETRIC DIVISION TRANSITION BY AGING USING MATHEMATICAL MODELING	7
3135 – KLF1-RELATED PROTEINS IN ERYTHROBLAST ISLAND MACROPHAGES - A PROTEOMIC STUDY	7
3117 – CATEGORIZED HEMATOLOGIC RESPONSE TO PEGCETACOPLAN VERSUS ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: POST HOC ANALYSIS OF PEGASUS PHASE 3 RANDOMIZED TRIAL DATA	7
3122 – SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA	6
Macrophages form erythropoietic niches and regulate iron homeostasis to adapt erythropoiesis in response to infections and inflammation	6
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms	6
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia	6
Cover 2: Editorial Board	6
3056 – VITAMIN C LIMITS MULTIPOTENT PROGENITOR SELF-RENEWAL AND CLONAL EXPANSION	6
3195 – LONG-TERM EX VIVO HEMATOPOIETIC STEM CELL (HSC) EXPANSION USING NOVEL BONE-LINING REINVIGORATING MESENCHYMAL STROMAL CELLS (RMSCS)	6
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment	6
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes	6
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy	6
3104 – TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF MURINE FETAL LIVER HEMATOPOIETIC STEM CELLS AT SINGLE CELL RESOLUTION	6

A new era of functional experimentation in human hematopoiesis and leukemia research	6
Integrins and their role in megakaryocyte development and function	6
Building bones for blood and beyond: the growing field of bone marrow niche model development	6
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis	6
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing	6
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS	5
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES	5
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY	5
3119 – DECIPHERING THE IMPACT OF TYPE 1 INTERFERON IN HUMAN CALR-MUTATED AND WILDTYPE HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELOPROLIFERATIVE NEOPLASMS VIA SINGLE-CELL MULTI-OMICS	5
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS	5
3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING	5
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL	5
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis	5
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION	5
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES	5
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION	5
1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS	5
3204 – NK CELL-DEFECTS OCCURRING ALREADY AT THE PRE-MDS STAGE IN NUP98-HOXD13 TRANSGENIC MOUSE MODEL	4
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA	4
3222 – THE SURROGATE HEMATOPOIETIC STEM CELL NICHE AS A TOOL TO UNDERSTAND HEMATOPOIETIC STEM CELL EXPANSION	4
3124 – POLYCOMB REPRESSIVE COMPLEX 1.1 INSUFFICIENCY PROMOTES THE DEVELOPMENT OF MYELOFIBROSIS	4
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells	4
3209 – SINGLE-CELL PROFILING OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS A GRADUAL TRANSITION FROM PRE-LEUKEMIA TO LEUKEMIA	4
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)	4
3215 – A SINGLE-CELL EXPRESSION ATLAS OF HUMAN AML LEUKEMIA-INITIATING CELLS UNRAVELS THE CONTRIBUTION OF HIF PATHWAY AND ITS THERAPEUTIC POTENTIAL	4
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia	4
3067 – ACUTE AND CHRONIC IMMUNE STIMULI FOR HEMATOPOIETIC STEM CELLS	4
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro	4
3210 – BIOLOGY AND FUNCTION OF CIRCULAR PCMDT1 (CP1) IN CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)	4
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS	4
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.	4
3033 – THE INTERACTION OF HBO1 AND MLL PROMOTES LEUKEMIA	4
3097 – AUTOIMMUNE INTERFERONOPATHY INDUCES A ‘TRAINED IMMUNITY’ PROGRAM IN HSC THAT PRIMES MACROPHAGES FOR INCREASED PATHOGEN KILLING AND INFLAMMATORY ACTIVITY	4
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL	4
Short Talk Presentations	3
2021 – THE BACTERIAL MICROBIOTA PROMOTES NORMAL HEMATOPOIESIS VIA INTERFERON ALPHA AND NOD1 SIGNALING PATHWAYS	3
1016 – INSIGHTS INTO ERYTHROPOIESIS AND MEGAKARYOPOIESIS AT THE SINGLE CELL LEVEL	3
3060 – PDGFRΒ+ CELLS PLAY A DUAL ROLE AS HEMATOPOIETIC PRECURSORS AND NICHE CELLS DURING MOUSE ONTOGENY	3
3203 – IDENTIFICATION OF DIFFERENTIATION ROOTS OF HEMATOPOIETIC STEM CELLS BY A PAIRED-DAUGHTER ASSAY COMBINED WITH MULTIPLE BARCODING	3
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS	3
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes	3
Immune control in acute myeloid leukemia	3
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE	3
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA	3
2022 – CHARACTERIZING HETEROGENEITY IN HEALTHY AND MALIGNANT HEMATOPOIETIC HIERARCHIES USING SINGLE CELL PROTEOMICS	3
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization	3
Functional and molecular profiling of hematopoietic stem cells during regeneration	3
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells	3
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS	3
3090 – CLONAL RECONSTRUCTION FROM CO-OCCURRENCE OF VECTOR INTEGRATION SITES ALLOWS ACCURATE QUANTIFICATION OF EXPANDING CLONES IN VIVO	3
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS	3
3002 – CIRCADIAN CUES REPROGRAM METABOLIC PATHWAYS IN LONG-TERM REPOPULATING HEMATOPOIETIC STEM CELLS	3
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY	3
Development and aging of resident endothelial stem cells in pre-existing blood vessels	3
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV	3
3114 – PROXIMITY DEPENDENT LABELING DESCRIBES ROLE OF ABELSON INTERACTOR 1 IN CENTROSOME BIOLOGY	3
3048 – MECHANISMS AND PROGNOSIS OF A20 MUTATION AND ABNORMAL EXPRESSION IN T-CELL MALIGNANCIES	3
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION	3
3074 – GLOBAL EPIGENOMIC REGULATION OF GENE EXPRESSION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY IKAROS	3
Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts	3
2029 – TFEB-MEDIATED ENDO-LYSOSOMAL ACTIVITY CONTROLS HEMATOPOIETIC STEM CELL FATE	3
3061 – THE NF-KkB PATHWAY REGULATES HETEROCHROMATIN AT INTRONIC LINE-1 AND HSC GENE EXPRESSION DURING IRRADIATION STRESS	3
3057 – HIGH SALT DIETS PROMOTE A TH17 CELL DRIVEN GUT-BONE AXIS TO REGULATE HAEMATOPOIESIS AND ATHEROSCLEROSIS	3
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.	3
3041 – CELLULAR MECHANISMS INVOLVED IN SERONEGATIVE HEMOLYTIC ANEMIAS	3
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA	3
1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION	3
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL	3
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study	3
3093 – SUBTYPE-SPECIFIC INDUCTION OF MITOCHONDRIAL APOPTOSIS AS A NOVEL THERAPEUTIC OPTION IN HIGH-FATALITY PEDIATRIC LEUKEMIA	3
Fetal allotransplant recipients are resistant to graft-versus-host disease	3
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs	3
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent	2
3007 – HUMAN HEMATOPOIETIC STEM CELLS POLARIZE AND FORM A SPECIFIC SYNAPSE WITH STROMAL CELLS OF THE BONE MARROW BY ENGAGING THE CXCL12/CXCR4 AXIS	2
3232- – INFLAMMATORY STRESS PROMOTES HETEROGENEOUS ACTIVATION OF IMMUNE RESPONSE PROGRAMS IN HUMAN HEMATOPOIETIC STEM CELLS	2
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES	2
2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION	2
1032 – STEM CELLS IN HUMAN AML	2
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils	2
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA	2

3120 – ENHANCED MYELO-ERYTHROID DIFFERENTIATION OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS IN A LOW OXYGEN ENVIRONMENT	2
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS	2
3221 – INVESTIGATING THE ROLE OF UBIQUITIN E3 LIGASE, FBXO21, IN THE REGULATION OF CYTOKINE SIGNALING WITHIN ACUTE MYELOID LEUKEMIA	2
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS	2
1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND	2
From Metcalf to myeloproliferative neoplasms – a personal journey	2
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS	2
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells	2
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT	2
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells	2
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS	2
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE	2
C-COUNT: a Convolutional Neural Network-Based Tool for Automated Scoring of Erythroid Colonies	2
3177 – RUNX FACTORS LAUNCH T CELL AND INNATE LYMPHOID CELL PROGRAMS VIA DIRECT BINDING AND GENE NETWORK-BASED MECHANISMS	2
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS	2
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT	2
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice	2
3050 – TRANSCRIPTOMIC PROFILING OF ACUTE MYELOID LEUKEMIA CORE BONE MARROW BIOPSIES REVEALS DECREASED ACTIVATION OF MESENCHYMAL STEM AND PROGENITORS IN PATIENTS UNRESPONSIVE TO INDUCTION CHEMOTHERAPY	2
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT	2
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING	2
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY	2
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS	2
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION	2
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy	2
Assay optimization for the objective quantification of human multilineage colony-forming units	2
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS	2
3223 – THE DEVELOPMENT OF A DIAGNOSTIC TOOL TO HELP PRIMARY CARE CLINICIANS MANAGE PATIENTS WITH SUSPECTED MYELOMA	2
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.	2
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION	1
Cover 2: Editorial Board	1
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS	1
3200 – RENIN-ANGIOTENSIN SYSTEM INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	1
A-to-I RNA editing and hematopoiesis	1
1010 – CONVERGENT SOMATIC EVOLUTION FROM EARLY LIFE IN A GERMLINE RIBOSOMOPATHY	1
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS	1
2001 – EMBRYONIC MACROPHAGES REGULATE THE SIZE OF THE DEFINITIVE HSC POOL	1
Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches	1
2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION	1
Cover 2: Editorial Board	1
1025 – BLOOD FOR LIFE: HEMATOPOIETIC STEM CELL WAVES FROM DEVELOPMENT INTO AGING	1
3021 – SINGLE-CELL RNASEQ REVEALS CELL ADHESION MOLECULE PROFILES OF SHORT-TERM AND LONG-TERM CORD BLOOD HEMATOPOIETIC STEM CELLS	1
3002 – DAMAGE-RESISTANT MYELOID-DERIVED SUPPRESSOR CELLS DRIVE THE RECOVERY AND REGENERATION OF THE BONE MARROW ENDOTHELIAL HEMATOPOIETIC NICHE BY ACTIVATING NOTCH SIGNALING	1
Nucleic acid metabolism: the key therapeutic target for myeloid tumors	1
3061 – STROMAL CELL-TRIGGERED DOWNREGULATION OF THE NUCLEOPORIN (NUP) FAMILY DRIVES TRANSFORMATION OF MYELODYSPLASIA TO ACUTE MYELOID LEUKEMIA	1
2016 – METALLOPROTEINASE INHIBITION REDUCES AML GROWTH, PREVENTS STEM CELL LOSS, AND IMPROVES CHEMOTHERAPY EFFECTIVENESS	1
1018 – HETEROGENEITY AND FUNCTIONAL SPECIALIZATION OF THE BONE MICROVASCULATURE	1
3099 – REGULATORY ROLE OF 3D DNA STRUCTURE IN HEMATOPOIESIS AND LEUKEMOGENESIS	1
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION	1
3106 – PROTEOMICS AND GENOMICS STUDIES REVEALED A NEW ROLE FOR MLL PARTIAL TANDEM DUPLICATION (PTD) IN MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)	1
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS	1
3127 – COMPREHENSIVE ATLAS OF MIXED-LINEAGE STATES	1
The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis	1
3148 – EMP- AND HSC-DERIVED NEUTROPHILS DYNAMICALLY CONTRIBUTE TO THE DEVELOPING MOUSE HEMATOPOIETIC SYSTEM	1
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL	1
1019 –	1
Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche	1
The multifaceted role of mitochondria in HSC fate decisions: energy and beyond	1
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia	1
3025 – UNCOVERING THE ROLE OF KDM5C IN NORMAL HEMATOPOIESIS	1
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone	1
1022 – THE DEVELOPMENTAL ORIGINS OF BLOOD AND BLOOD CANCER	1
3148 – GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS	1
3044 – SUPPRESSION OF ACUTE MYELOID LEUKEMOGENESIS BY A NONCANONICAL IRE1Α-XBP1 SIGNALING MECHANISM	1
3051 – HEMATOPOIETIC STEM CELLS DEPEND ON AUTOPHAGY TO MAINTAIN PROTEIN HOMEOSTASIS	1
3007 – T-CELL MEDIATED STEM-LIKE PLASTICITY OF GERMINAL CENTER B CELLS	1
3139 – DEFECTIVE MYELOID LINEAGE PRIMING AND GENOME INSTABILITY UNDERLIE MARROW FAILURE IN A ZEBRAFISH GATA2 DEFICIENCY MODEL	1
2001 – THE ENDOSOMAL ADAPTOR PROTEIN MYCT1 CONTROLS ENVIRONMENTAL SENSING IN HUMAN HEMATOPOIETIC STEM CELLS	1
3068 – CBX7 INHIBITORS BLOCK CELL PROLIFERATION AND INDUCE DIFFERENTIATION OF ACUTE MYELOID AND LYMPHOBLASTIC LEUKEMIA CELLS	1
3037 – POLYCOMB GROUP PROTEIN MEL18 REGULATES HEMATOPOIETIC STEM CELL BEHAVIORS VIA MODULATING THE EPIGENOME AND HIGHER ORDER CHROMATIN STRUCTURE	1
3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT	1
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR	1
ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells	1
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT	1
3142 – INVESTIGATING THE UBIQUITIN E3 LIGASE, FBXO21, IN REGULATION OF HEMATOPOIETIC STEM CELLS	1
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL	1
3202 – M. AVIUM INDUCES EPIGENETIC REPROGRAMMED HSPC-TRAINED IMMUNITY THAT ALTERS DOWNSTREAM MYELOID IMMUNE FUNCTION.	1
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells	1
3179 – ID1 ABLATION RESCUES CLONAL HEMATOPOIESIS AND DELAYS DISEASE PROGRESSION IN TET2 NULL MICE	1
3047 – A NAD+ METABOLIC CHECKPOINT REGULATES HEMATOPOIETIC STEM CELL ACTIVATION AND AGING	1
3014 – MEAN PLATELET VOLUME - A NOVEL BIOMARKER IN VARIOUS CARDIOVASCULAR DISEASES	1
3184 – ONCOSTATIN M SIGNALING MEDIATES DNMT3A-MUTANT HEMATOPOIETIC STEM CELL FITNESS IN THE AGED BONE MARROW MICROENVIRONMENT	1
3095 – SEX-SPECIFIC DIFFERENCES IN PLATELET PARAMETERS AND THE UTILITY OF MEAN PLATELET VOLUME/ PLATELET COUNT RATIO IN DIAGNOSING IRON DEFICIENCY ANEMIA	1
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer	1
Cover 2: Editorial Board	1
3106 – GENOME-WIDE CRISPR SCREENING IDENTIFIES THE E3 UBIQUITIN LIGASE HERC1 AS A MODULATOR OF THE RESPONSE TO NUCLEOSIDE ANALOGS IN ACUTE MYELOID LEUKEMIA	1
3004 – ACUTE MYELOID LEUKEMIA CELLS REQUIRE 18-CARBON LONG FATTY ACIDS FOR PROTEIN S-ACYLATION TO MAINTAIN MITOCHONDRIAL ACTIVITY AND METABOLIC PLASTICITY	1
CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis	1
3081 – LCK DRUG TARGETING IN PAX5 REARRANGED CASES IN POOR RISK CHILDHOOD B-CELL PRECURSORS ACUTE LYMPHOBLASTIC LEUKAEMIA	1
Intrinsically magnetic susceptibility in human blood and its potential impact on cell separation: Non-classical and intermediate monocytes have the strongest magnetic behavior in fresh human blood	1
1023 – THE IMPORTANCE OF STEM CELL EXPANSION IN TOMORROW'S MEDICINE	1
3137 – A MODIFIED ACTIVIN RECEPTOR TYPE IIB LIGAND TRAP (RAP-536) IMPROVES ANEMIA IN SF3B1K700E MICE BY PROMOTING EARLY-STAGE ERYTHROPOIESIS AND IMPROVING ALTERNATIVE SPLICING	1
Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm	1
3004 – GENETIC APPROACHES FOR MODELING SUBCLONAL MUTATIONS IN ACUTE MYELOID LEUKEMIA	1
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	1
3139 – THE ROLE OF MYELOID CELLS HARBORING CLONAL HEMATOPOIESIS MUTATIONS IN ALZHEIMER'S DISEASE	1